TRPV1
MOLECULAR TARGETtransient receptor potential cation channel subfamily V member 1
TRPV1 (transient receptor potential cation channel subfamily V member 1) is targeted by 20 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TRPV1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | anandamide | 4.16 | 63 |
| 2 | propofol | 4.01 | 54 |
| 3 | capsazepine | 3.56 | 34 |
| 4 | oleoylethanolamide | 3.53 | 33 |
| 5 | cannabinol | 2.89 | 17 |
| 6 | cannabigerol | 2.71 | 14 |
| 7 | cannabidivarin | 2.56 | 12 |
| 8 | cannabichromene | 2.48 | 11 |
| 9 | lysophosphatidic acid | 2.40 | 10 |
| 10 | tetrahydrocannabivarin | 2.20 | 8 |
| 11 | liquiritin | 2.20 | 8 |
| 12 | sb 705498 | 2.08 | 7 |
| 13 | abt 102 | 1.95 | 6 |
| 14 | voacangine | 1.95 | 6 |
| 15 | cbd | 1.10 | 2 |
| 16 | cannabidiol | 1.10 | 2 |
| 17 | Camphor | 0.69 | 1 |
| 18 | Framycetin | 0.69 | 1 |
| 19 | Leukotriene B4 | 0.69 | 1 |
| 20 | neomycin | 0.69 | 1 |
About TRPV1 as a Drug Target
TRPV1 (transient receptor potential cation channel subfamily V member 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 20 compounds with documented TRPV1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TRPV1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.